Please disable your adblock and script blockers to view this page

Coronavirus Vaccine: MRNA Stock Rockets On Funding News; Gilead Pops On Leaked Report - Investor's Business Daily

Positivity     50%   
   Negativity   50%
The New York Times
Write a review:

Shares of MRNA stock rocketed Friday after the biotech said it will receive up to $483 million in federal funding for its coronavirus vaccine.

As said here by Investor's Business Daily